GGrantIndex
← Leaderboards

Debra Burnin

Sri International

$9,670,591
Attributed
$9,670,591
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.4M · FY202225
$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25

Funding mix

By agency

NIH$9,670,591 · 2

By mechanism

N01$9,670,591 · 2

Top collaborators

No co-investigators on record.

Most similar at Sri International

Same institution · by research overlap

Others in their field

Other Rising Stars on “National Institute Of Child Health And Human Development

Research focus

National Institute Of Child Health And Human DevelopmentIn VivoEvaluationAnimalsIn VitroDrug FormulationsContraceptive AgentsDesignFormulationBiological TestingToxic EffectOvulationLot ProductionPre-ClinicalContraceptive MethodsProduct DevelopmentClinical LotResearch Clinical TestingPharmacokinetics And PharmacodynamicsPlasmaPharmacologic SubstanceResearch SupportPlayPharmaceutical Preparations

Grant awards (12)

NONCLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS FOR MEN AND/OR WOMEN$684,493
N01 · FY2025 · HD · contact PI
BIOLOGICAL TESTING FACILITY-REGULATORY, DATA ANALYSIS, DATABASE, AND PROJECT MANAGEMENT$149,973
N01 · FY2025 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) – GOOD LABORATORY PRACTICE (GLP) TOXICOLOGY AND FERTILITY AND EARLY EMBRYONIC DEVELOPMENT (FEED) STUDIES AND PRECLINICAL STUDIES OF CONTRACEPTIVES$2,369,376
N01 · FY2024 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS$1,017,684
N01 · FY2024 · HD · contact PI
PK/PD, METABOLIC, AND PRECLINICAL STUDIES - SRI INTERNATIONAL$2,084,983
N01 · FY2023 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - FORMULATION AND PHARMACEUTICAL CHARACTERIZATION OF MULTIPURPOSE PREVENTION CONTRACEPTION PREVENTION$49,975
N01 · FY2023 · HD · contact PI
BIOLOGICAL TESTING FACILITY - DMAU$3,556
N01 · FY2023 · HD · contact PI
BIOLOGICAL TESTING FACILITY - STABILITY TESTING, CLINICAL FORMULATION DEVELOPMENT AND MANUFACTURING ACTIVITIES OF CONTRACEPTIVE AGENTS$1,199,506
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - NONCLINICAL FEMALE CONTRACEPTIVE DEVELOPMENT SERVICES$1,099,997
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY – IN VITRO METABOLIC AND IN VIVO PRECLINICAL STUDIES$604,936
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF) - NONCLINICAL MALE CONTRACEPTIVE DEVELOPMENT SERVICES$352,571
N01 · FY2022 · HD · contact PI
BIOLOGICAL TESTING FACILITY (BTF): TASK ORDER 12- "FORMULATION AND PHARMACEUTICAL CHARACTERIZATION OF MULTIPURPOSE PREVENTION CONTRACEPTION PREVENTION$53,541
N01 · FY2022 · HD · contact PI